Cyclerion Therapeutics (CYCN) Shareholder's Equity Growth (1y) (2019 - 2025)
Cyclerion Therapeutics (CYCN) Shareholder's Equity Growth (1y) (2019 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Cyclerion Therapeutics |
11.50 Mn |
8.26 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
2.66% |
| Sep 30, 2025 |
16.35% |
| Jun 30, 2025 |
-2.43% |
| Mar 31, 2025 |
-11.52% |
| Dec 31, 2024 |
-21.60% |
| Sep 30, 2024 |
-36.32% |
| Jun 30, 2024 |
70.54% |
| Mar 31, 2024 |
152.82% |
| Dec 31, 2023 |
8.00% |
| Sep 30, 2023 |
-22.10% |
| Jun 30, 2023 |
-79.69% |
| Mar 31, 2023 |
-89.40% |
| Dec 31, 2022 |
-78.34% |
| Sep 30, 2022 |
-70.70% |
| Jun 30, 2022 |
-61.12% |
| Mar 31, 2022 |
-23.54% |
| Dec 31, 2021 |
-18.90% |
| Sep 30, 2021 |
-25.17% |
| Jun 30, 2021 |
-1.33% |
| Mar 31, 2021 |
-40.60% |
